Early corticosteroid withdrawal in recipients of renal allografts: a single-center report of ethnically diverse recipients and recipients of marginal deceased-donor kidneys.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 23001353)

Published in Transplantation on October 27, 2012

Authors

Meredith J Aull1, Darshana Dadhania, Cheguevara Afaneh, David B Leeser, Choli Hartono, Jun B Lee, David Serur, Joseph J Del Pizzo, Manikkam Suthanthiran, Sandip Kapur

Author Affiliations

1: Division of Transplantation Surgery, Department of Surgery, NewYork-Presbyterian/Weill Cornell Medical Center, New York, NY, USA.

Articles by these authors

HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42

Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40

Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer. Clin Cancer Res (2004) 5.40

Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med (2005) 5.02

Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest (2010) 3.59

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57

Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med (2007) 2.86

Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation (2002) 2.86

MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A (2009) 2.36

Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A (2007) 2.10

Remission of aseptic inflammatory ascites after nephrectomy of a failed allograft. Am J Kidney Dis (2007) 1.95

Rapamycin is an effective inhibitor of human renal cancer metastasis. Kidney Int (2003) 1.83

Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis. Semin Dial (2005) 1.68

Comparison of laparoendoscopic single-site donor nephrectomy and conventional laparoscopic donor nephrectomy: donor and recipient outcomes. Urology (2011) 1.62

Deceased-donor kidney transplantation: improvement in long-term survival. Nephrol Dial Transplant (2010) 1.60

Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation (2014) 1.60

Kidney transplant chains amplify benefit of nondirected donors. JAMA Surg (2013) 1.52

Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation (2008) 1.50

Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int (2004) 1.48

Trends and inequalities in the surgical management of ureteric calculi in the USA. BJU Int (2013) 1.47

Outcomes of laparoscopic donor nephrectomy without intraoperative systemic heparinization. J Urol (2010) 1.45

Is right-sided laparoendoscopic single-site donor nephrectomy feasible? Urology (2011) 1.43

Successful transplantation of single kidneys from pediatric donors weighing less than or equal to 10 kg into standard weight adult recipients. Transplantation (2010) 1.39

Minimally invasive surgical management of ureteropelvic junction obstruction: laparoscopic and robot-assisted laparoscopic pyeloplasty. J Long Term Eff Med Implants (2003) 1.37

Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy. Transplantation (2002) 1.33

Divergent generation of heterogeneous memory CD4 T cells. J Immunol (2006) 1.17

Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. Transplantation (2003) 1.16

MicroRNAs: small RNAs with big effects. Transplantation (2010) 1.15

Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy. Hypertension (2012) 1.14

Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice. Transplantation (2005) 1.13

Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study. BMC Med (2014) 1.10

Hyperexpression of Foxp3 and IDO during acute rejection of islet allografts. Transplantation (2007) 1.08

CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation (2003) 1.07

Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation (2004) 1.07

Mitochondrial targeting with antioxidant peptide SS-31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function. J Am Soc Nephrol (2006) 1.05

Transforming growth factor beta and progression of renal disease. Kidney Int Suppl (2003) 1.04

MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis. Transplantation (2012) 1.03

Laparoscopic vs open partial nephrectomy in consecutive patients: the Cornell experience. BJU Int (2005) 1.03

Transforming growth factor beta signaling, vascular remodeling, and hypertension. N Engl J Med (2006) 1.01

Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation (2010) 0.99

A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation. J Vasc Access (2012) 0.98

Noninvasive diagnosis of acute rejection of renal allografts. Curr Opin Organ Transplant (2010) 0.98

Laparoscopic adrenalectomy for large adrenal masses. Curr Urol Rep (2008) 0.98

Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis. Transplantation (2012) 0.98

Comparison of complications of laparoscopic versus laparoendoscopic single site donor nephrectomy using the modified Clavien grading system. J Urol (2011) 0.98

The advantages of hand-assisted laparoscopy. Curr Urol Rep (2004) 0.97

Intrarenal color duplex ultrasonography: a window to vascular complications of renal transplants. J Ultrasound Med (2007) 0.97

Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation (2003) 0.96

Analysis of failure in living donor liver transplantation: differential outcomes in children and adults. World J Surg (2003) 0.95

Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication. Transplantation (2008) 0.95

Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma. Urology (2005) 0.94

Measurement of apoptosis of intact human islets by confocal optical sectioning and stereologic analysis of YO-PRO-1-stained islets. Transplantation (2005) 0.94

Genomic biomarkers correlate with HLA-identical renal transplant tolerance. J Am Soc Nephrol (2013) 0.94

Adrenal-preserving minimally invasive surgery: the role of laparoscopic partial adrenalectomy, cryosurgery, and radiofrequency ablation of the adrenal gland. Curr Urol Rep (2003) 0.92

Preoperative radiographic parameters predict long-term renal impairment following partial nephrectomy. World J Urol (2011) 0.91

Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts. Transplantation (2010) 0.90

Proapoptotic Bax is hyperexpressed in isolated human islets compared with antiapoptotic Bcl-2. Transplantation (2002) 0.90

Enforced c-REL deficiency prolongs survival of islet allografts1. Transplantation (2002) 0.89

Laparoendoscopic single site live donor nephrectomy: initial experience. J Urol (2010) 0.89

Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients. Transplantation (2013) 0.88